top of page

Driving innovation in healthcare and biotech through strategic funding in Europe and the Middle East.

Discover Our Strategy

We Are Visionaries

Transforming the future of health care with our innovative genetic engineering technology.

Keter Lifesciences is a purpose-driven company committed to advancing innovation in healthcare. Our mission: to support life sciences companies in their growth and fundraising efforts, helping build a better medical future together.

Keter LifeSciences Research
Keter LifeSciences Research
Keter LifeSciences Research

Research & Technology

With over 20 years of combined experience across biotech, pharma, medtech, and private equity, our team leverages a powerful network of experts, investors, and strategic partners to structure, advise, and execute tailor-made fundraising strategies.

Immune Dendritic cells

1

Fundraising Support

Empowering innovation with the right capital at the right stage.

We assist innovative life sciences companies in securing equity funding at every stage of development — from early validation to commercial scaling.
Our team helps prepare compelling investor materials (teasers, pitch decks, financial models), define strategic funding roadmaps, and negotiate term sheets with venture capital funds, family offices, and corporate investors.

Continuation_shutterstock_2145331769_1000x640_-_28de80_-_d92af086c55b3fc1c3fa85b9972b02dfb

2

Investment vehicle or SPV structuring

Flexible and compliant structures to match investor and project needs.

We design and structure investment vehicles (SPVs, CLNs, convertible notes) tailored to each client’s capital strategy.
Whether you're pooling investors through a dedicated entity or seeking to isolate risk and governance, we coordinate with legal and financial experts to ensure compliance, efficiency, and alignment with investor expectations.

SPV-Chart-1024x671.png

3

Targeted introductions to international investors

Global capital access through curated and qualified connections.

Leveraging our trusted network of global investors, we connect high-potential biotech and medtech projects with the right capital partners.
Each introduction is qualified and curated — from venture capital and private equity firms to strategic corporates and health-focused family offices in Europe, North America, and the Middle East.

ChatGPT Image 12 juin 2025, 14_19_41.png

We Stand For

Innovation, Health, Humanity.

Working with Keter Lifesciences was a game-changer for our company. Their strategic guidance and investor network helped us secure funding faster than we imagined, and with the right partners. They truly understand the unique challenges of building a biotech company.

Dr. A. Moreau, CEO of a clinical-stage biotech startup

Collabortor


 

At Keter Lifesciences, we believe that science can only reach its full potential when paired with strategic capital and the right partners. Our mission is simple yet ambitious: to empower breakthrough innovations in healthcare by supporting the companies and founders behind them.

Over the past two decades, our team has built deep expertise at the intersection of biotechnology, finance, and entrepreneurship. We’ve worked alongside visionary leaders, researchers, and investors who are not only shaping the future of medicine — but saving lives.

Keter Lifesciences was born from a shared conviction: that the challenges of capital raising, strategic alignment, and global visibility in life sciences require a dedicated partner — one who understands the scientific journey, the financial complexity, and the human stakes involved.

We act with discretion, precision, and purpose. Whether it’s securing early-stage funding, structuring an investment vehicle, or introducing the right strategic investor, we are committed to one goal: unlocking the full value of innovation in life sciences.

 

To our partners, collaborators, and future clients — we thank you for your trust and look forward to building a healthier world together.

 

Warm regards,


Herve UZAN

CEO and Co-Founder of Keter Lifesciences

Keter Herve UZAN

KETER LIFESCIENCES in Numbers

4

Employees

250M$

Invested

12

Partners Worldwide

15

Publications

22

Ongoing Research Programs

Join Our Team

We’re looking for highly-motivated and talented people to join our innovative team. Submit your application today to join the BGS journey!

Senior Project Manager

San Francisco, CA

Associate Director, Drug Delivery

San Francisco, CA

Data Scientist, IT

San Francisco, CA

Press

KTRL appoints Daniel MAZIGH as Board Director

-

KTRL just fundraised
2 Million Euro for
ADOCIA

The Figaro :
Adocia raised 9,7 millions euro.

Join The KTRL Newsletter

Be the first to receive the latest news and updates.

bottom of page